Julie Price Hiller

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

David Miles, Joseph Gligorov, Fabrice André et al. · Annals of Oncology · 2021 · 729 citations · Full text

Medicine, Oncology, Pharmacology +17

Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial

Elizabeth A. Mittendorf, Biao Lu, Michelle Melisko et al. · Clinical Cancer Research · 2019 · 213 citations

Veterinary Medicine, Immunology, Oncology +17

Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer

Michael P. Chu, J. Randolph Hecht, Dennis J. Slamon et al. · JAMA Oncology · 2016 · 106 citations · Full text

Medicine, Oncology, Pharmacology +17

Predictors of Pathologic Complete Response After Neoadjuvant Treatment for Rectal Cancer: A Multicenter Study

Dawn Elizabeth Armstrong, Soundouss Raissouni, Julie Price Hiller et al. · Clinical Colorectal Cancer · 2015 · 68 citations

Medicine, Oncology, Surgery +17

Rationale and design of the Diet Restriction and Exercise-induced Adaptations in Metastatic breast cancer (DREAM) study: a 2-arm, parallel-group, phase II, randomized control trial of a short-term, calorie-restricted, and ketogenic diet plus exercise during intravenous chemotherapy versus usual care

Amy A. Kirkham, Karen King, Anil A. Joy et al. · BMC Cancer · 2021 · 37 citations · Full text

Medicine, Nutritional Sciences, Oncology +17